  See all
 |
Articles: Lung/Thoracic Oncology |
Prior Articles
Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer
Pathology International, 10/30/09
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09 Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
Journal of Clinical Oncology, 10/29/09 New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09 Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Modern Pathology, 10/28/09 1,3-Butadiene, Styrene and Lung Cancer Among Synthetic Rubber Industry Workers
Journal of Occupational and Environmental Medicine, 10/28/09 Weekly paclitaxel and cisplatin in the treatment of elderly advanced non-small cell lung cancer
Chinese Journal of Lung Cancer, 10/27/09 Living with mesothelioma. A literature review
European Journal of Cancer Care, 10/27/09
Revew Article
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09 Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: CCTGcctg and SWOG study N0426
Journal of Clinical Oncology, 10/26/09 Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer
Cancer, 10/26/09
Exclusive Author Commentary State-of-the-art lung cancer radiation therapy
Expert Review of Anticancer Therapy, 10/26/09 Influence of Narrow Band Imaging (NBI) Videobronchoscopy on the Assessment of Central Lung Cancer Extension and Therapeutic Decision
Cancer Investigation, 10/26/09 Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09 Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
Cancer Science, 10/23/09 Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09 Radiochemotherapy in the elderly with lung cancer
Expert Review of Anticancer Therapy, 10/22/09 Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer
Human Pathology, 10/22/09 Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy
Expert Review of Anticancer Therapy, 10/22/09 Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue
Expert Review of Anticancer Therapy, 10/22/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
